Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bipin Kishore Kullu"'
Autor:
Dilip Kumar Patel, Ranjeet Singh Mashon, Prasanta Purohit, Siris Patel, Satyabrata Meher, Snehadhini Dehury, Chhatray Marndi, Kishalaya Das, Bipin Kishore Kullu, Padmalaya Das
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015050-e2015050 (2015)
Although several studies have supported that sickle cell trait (HbAS) protects against falciparum malaria, the exact mechanism by which sickle gene confers protection is unclear. Further, there is no information on the influence of sickle gene on par
Externí odkaz:
https://doaj.org/article/d6935bcc41ce4c32adb49f2532fcab03
Publikováno v:
Indian Journal of Case Reports. 4:172-175
The severity of sickle cell disease may vary from asymptomatic to severe form including episodes of painful events and severe anemia. This hospital-based study was carried out to study the incidence of different clinical signs and symptoms in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63a1a8ddddb5479cf620a43721fd4539
https://doi.org/10.32677/ijcr.2018.v04.i03.001
https://doi.org/10.32677/ijcr.2018.v04.i03.001
Autor:
Satyabrata Meher, Dilip Kumar Patel, Snehadhini Dehury, Alok Kumar Mohapatra, Kishalaya Das, Lulup Kumar Sahoo, Prasanta Purohit, Nayan Kumar Patel, Siris Patel, Bipin Kishore Kullu
Publikováno v:
Pediatric Blood & Cancer. 62:1017-1023
Background Despite compelling evidence that hydroxyurea is safe and effective in sickle cell disease, it is prescribed sparingly due to several barriers like knowledge gaps in certain genotypes, apprehension about its safety and toxicity, and limited
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::decb0a2fbc5cc851019c66fdd59c2641
https://doi.org/10.1002/pbc.25391
https://doi.org/10.1002/pbc.25391
Autor:
Lulup Kumar, Sahoo, Bipin Kishore, Kullu, Siris, Patel, Nayan Kumar, Patel, Pragyan, Rout, Prasanta, Purohit, Satyabrata, Meher
Publikováno v:
The Journal of the Association of Physicians of India. 65(6)
Male Sickle cell disease (SCD) patients often have moderate to severe hypogonadism resulting in abnormal seminal fluid parameters due to testicular dysfunction. Hydroxyurea (HU), the only drug found to be effective in preventing morbidity and mortali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ec3a3b61f2ea25871b510bca892ca1d7
https://pubmed.ncbi.nlm.nih.gov/28782309
https://pubmed.ncbi.nlm.nih.gov/28782309
Publikováno v:
International Journal of Research in Medical Sciences. 6:1950
Background: Sickle cell disease (SCD) an inheritable disorder of haemoglobin structure resulting from substitution of valine for glutamic acid at 6th position of β-globin chain of haemoglobin(HbS), which polymerizes on deoxygenation and undergoes to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ce39e10439d318dbc06cfaeb199175b
https://doi.org/10.18203/2320-6012.ijrms20182017
https://doi.org/10.18203/2320-6012.ijrms20182017
Autor:
Snehadhini, Dehury, Prasanta, Purohit, Siris, Patel, Satyabrata, Meher, Bipin Kishore, Kullu, Lulup Kumar, Sahoo, Nayan Kumar, Patel, Alok Kumar, Mohapatra, Kishalaya, Das, Dilip Kumar, Patel
Publikováno v:
Pediatric bloodcancer. 62(6)
Despite compelling evidence that hydroxyurea is safe and effective in sickle cell disease, it is prescribed sparingly due to several barriers like knowledge gaps in certain genotypes, apprehension about its safety and toxicity, and limited resources.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6a7562dcb263dd318302b5dadcb20189
https://pubmed.ncbi.nlm.nih.gov/25546091
https://pubmed.ncbi.nlm.nih.gov/25546091
Autor:
Nayan Kumar Patel, Satyabrata Meher, Prasanta Purohit, Lulup Kumar Sahoo, Siris Patel, Bipin Kishore Kullu, Pragyan Rout
Publikováno v:
Journal of Applied Hematology, Vol 7, Iss 3, Pp 90-94 (2016)
Context: Male sickle-cell disease (SCD) patients often have moderate to severe hypogonadism resulting in abnormal seminal fluid parameters. Hydroxyurea (HU) used in SCD patients has been found to further aggravate the testicular dysfunction. Aims: To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cea970225079c4c7bac1b1cb23f89a13
https://doi.org/10.4103/1658-5127.192984
https://doi.org/10.4103/1658-5127.192984
Autor:
Dehury, Snehadhini, Purohit, Prasanta, Patel, Siris, Meher, Satyabrata, Kullu, Bipin Kishore, Sahoo, Lulup Kumar, Patel, Nayan Kumar, Mohapatra, Alok Kumar, Das, Kishalaya, Patel, Dilip Kumar
Publikováno v:
Pediatric Blood & Cancer; Jun2015, Vol. 62 Issue 6, p1017-1023, 7p